James Whelan
About James Whelan
James Whelan is an Associate Director of Project Management with extensive experience in pharmaceutical research and development, currently working at BioXcel Therapeutics Inc., Daiichi Sankyo, Inc., and Bristol-Myers Squibb.
Title and Responsibilities
James Whelan holds the position of Associate Director Project Management at Bristol-Myers Squibb, and he is involved in leadership roles at BioXcel Therapeutics Inc. and Daiichi Sankyo, Inc. His responsibilities include managing cross-functional teams through various stages of drug development and ensuring the achievement of project goals in complex matrix environments.
Company Experience
James Whelan is currently associated with three prominent companies: BioXcel Therapeutics Inc. in New Haven, CT; Daiichi Sankyo, Inc. in Edison, NJ; and Bristol-Myers Squibb in Wallingford, CT. His roles in project management and leadership involve comprehensive oversight of project timelines, budgets, and resource allocation.
Previous Roles
James Whelan has a robust history in the pharmaceutical industry, having served as Global Clinical Project Manager & Principal Research Scientist at Bayer Pharmaceuticals in West Haven, Connecticut, from 2000 to 2007. Prior to that, he worked at Novartis Institutes for BioMedical Research (NIBR) in Summit, New Jersey, from 1995 to 2000 and at the Glaxo Institute for Molecular Biology in Geneva Area, Switzerland from 1990 to 1995.
Educational Background
James Whelan earned his Bachelor of Science (B.Sc.) in Pharmacology & Biochemistry and his Doctor of Philosophy (Ph.D.) in Molecular Pharmacology from University College Dublin. He furthered his studies with a Post-Doctoral Fellowship in Molecular Physiology at Vanderbilt University from 1987 to 1990.
Skills and Expertise
James Whelan brings over twenty years of international experience in pharmaceutical research and development across multiple therapeutic areas. He is adept at managing project teams, driving team strategy, and planning to meet project objectives. His expertise also includes timeline, budget, and resource management, along with significant experience working with external partners on drug development projects.